Benefits
Traditional use for tiredness, with no human trial of Codonopsis alone
No published clinical trial has tested Codonopsis pilosula on its own for fatigue. The antifatigue findings come from mouse experiments, and the qi tonifying use is a matter of tradition rather than a measured effect in people.
Registered cancer care trial, results not yet published
A double blind trial registered as NCT05613465 at Zhejiang Provincial People's Hospital is testing a Codonopsis pilosula oral liquid against placebo alongside chemotherapy after pancreatic cancer surgery, with cancer related fatigue as the outcome. It began in 2022, plans 100 participants and has published no results, so it does not yet show that Codonopsis does anything.
COPD herbal formulae meta-analysis
A systematic review and meta-analysis of COPD herbal formulae pooled 48 randomized trials of Dang shen containing formulas and reported better lung function, quality of life and walking distance. Codonopsis was one herb among several in those formulas, and the reviewers judged the trials methodologically flawed and the evidence not adequate to support routine use outside Chinese medicine practice.
Antifatigue + antihypoxia polysaccharides
Polysaccharides and oligosaccharides show antifatigue and antihypoxia activities in mice. This is animal evidence only, and it has not been shown to carry over to people.
Gastric ulcer protective
Rat studies report protection of the stomach lining. No human study has looked at this. Mechanistic basis for the TCM 'spleen-tonifying' digestive indications.
Active constituents: tangshenosides, syringin, polysaccharides
Tangshenosides are steroidal glycosides; tangshenoside I is structurally similar to ginsenosides (the classic Panax ginseng bioactives). Syringin (eleutheroside B) is a phenylpropanoid with immunomodulatory and antifatigue effects, shared with Eleutherococcus (Siberian ginseng). Polysaccharides drive much of the antifatigue and immunomodulatory activity. The chemistry overlaps with Panax ginseng and Eleutherococcus, although similar molecules do not guarantee similar effects in the body.
Honest framing — 'poor man's ginseng' less stimulating
Distinguishing positioning: Chinese medicine treats it as a gentler and cheaper stand in for Panax ginseng. That comparison comes from traditional practice rather than research, and no trial has compared the two. Most clinical evidence is in TCM combination formulas (Change of Season Soup, Si Jun Zi Tang, etc.) rather than isolated Codonopsis.
Mechanism of action
HPA axis modulation (saponins)
Saponins (tangshenosides) have been proposed to act on stress hormone pathways. This is a laboratory idea shared across the adaptogen herbs, and it has not been measured in people taking Codonopsis.
Polysaccharide + oligosaccharide antifatigue
Polysaccharides and oligosaccharides show direct antifatigue and antihypoxia activity. These results come from animal experiments and are a possible explanation rather than a demonstrated effect in people.
Cytokine balance immunomodulation
Multi-component cytokine balance modulation — supports the TCM immune-tonic positioning.
Gastric mucosa cytoprotection
Gastric mucosa cytoprotective mechanism. Biochemical basis for the TCM 'spleen-tonifying' digestive indications.
Phenolic anti-inflammatory + antioxidant
Phenolic acid compounds provide anti-inflammatory and antioxidant activity — broad supporting mechanism.
Codonopsine vasodilation (animal models)
Codonopsine alkaloid shows mild hypotensive vasodilation in animal models. Mild cardiovascular mechanism; clinical translation has not been demonstrated.
Clinical trials
Literature and registry check rather than a trial. No published clinical trial of Codonopsis pilosula alone was found.
Not applicable, because no such trial has been published.
A search of PubMed and the trial registries found no published clinical trial of Codonopsis pilosula taken on its own, for fatigue or for anything else. The human research to date is on multi herb Chinese formulas that contain Dang shen alongside other herbs.
NCT05613465 Zhejiang Provincial People's Hospital double-blind clinical trial.
Adults with pancreatic cancer after radical surgery and on adjuvant chemotherapy. 100 participants planned.
NCT05613465 Zhejiang Provincial People's Hospital double-blind clinical trial. Adjuvant chemotherapy plus Codonopsis pilosula Nannf oral liquid (approved listed Chinese product) vs placebo for pancreatic carcinoma post radical surgery (gemcitabine plus albumin paclitaxel first line per NCCN). The trial was registered in 2022 with 100 participants planned and is listed as recruiting. No results have been published, so it tells us nothing yet about whether Codonopsis helps.
Systematic review and meta-analysis of 48 randomized trials of Dang shen containing herbal formulas in COPD. Shergis JL and colleagues, 2015, Phytotherapy Research 29(2):167-186, PMID 25336444.
Adults with chronic obstructive pulmonary disease, pooled across 48 randomized trials.
Shergis JL and colleagues, 2015, Phytotherapy Research 29(2):167-186. Pooling 48 randomized trials, Dang shen formulas improved forced expiratory volume in one second against usual drug treatment and improved quality of life against placebo. Codonopsis was only one herb among several in those formulas, and the reviewers found methodological flaws and concluded the evidence is not adequate to support routine use.